PT - JOURNAL ARTICLE AU - Morgenstern, José AU - Redondo, José N. AU - De León, Albida AU - Canela, Juan Manuel AU - Torres, Nelson AU - Tavares, Johnny AU - Minaya, Miguelina AU - López, Óscar AU - María Plácido, Ana AU - Castillo, Ana AU - Peña Cruz, Rafael AU - Merette, Yudelka AU - Toribio, Marlenin AU - Francisco, Juan Asmir AU - Roca, Santiago TI - The use of compassionate Ivermectin in the management of symptomatic outpatients and hospitalized patients with clinical diagnosis of COVID-19 at the Medical Center Bournigal and the Medical Center Punta Cana, Rescue Group, Dominican Republic, from may 1 to august 10, 2020 AID - 10.1101/2020.10.29.20222505 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.29.20222505 4099 - http://medrxiv.org/content/early/2020/11/03/2020.10.29.20222505.short 4100 - http://medrxiv.org/content/early/2020/11/03/2020.10.29.20222505.full AB - No antiviral has been shown to reduce mortality in SARS-COV-2 patients to date. In the present observational and retrospective report, 3,099 patients with a definitive or highly probable diagnosis of infection due to COVID-19 were evaluated between May 1st to August 10th, 2020, at Centro Medico Bournigal (CMBO) and Centro Medico Punta Cana (CMPC), and all received compassionate treatment with Ivermectin. A total of 2,706 (87.3%) were discharged for outpatient treatment, all with mild severity of the infection. In 2,688 (99.33%) with outpatient treatment, the disease did not progress to warrant further hospitalization and there were no deaths. In 16 (0.59%) with outpatient treatment, it was necessary their subsequent hospitalization to a room without any death. In 2 (0.08%) with outpatient treatment, it was necessary their admission to the Intensive Care Unit (ICU) and 1 (0.04%) patient died. There were 411 (13.3%) patients hospitalized, being admitted at a COVID-19 room with a moderate disease 300 (9.7%) patients of which 3 (1%) died; and with a severe to critical disease were hospitalized in the ICU 111 (3.6%), 34 (30.6%) of whom died. The mortality percentage of patients admitted to the ICU of 30.6%, is similar with the percentage found in the literature of 30.9%. Total mortality was 37 (1.2%) patients, which is much lower than that reported in world statistics, which are around 3%.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIt was a retrospective observational studyFunding StatementThe authors declare that none of them have a conflict of interests with the study that serves at the basis for this publication, none have received benefits or financial funding that could influence the results.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All relevant ethical guidelines have been followed adn aproved by the ethics committee at Bournigal Medical Center and Punta Cana Medical Center(Rescue Group).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data was collected in the medical charts of all the patients involved in this observational study at the Bournigal Medical Center and the Punta Cana Medical Center.